Harvard Apparatus Regenerative Technology, Inc.
For the period ended Sep 30, 2025. Filed Nov 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 7, 2025
HRGNStored price and day change unavailable
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by undersigned thereunto duly authorized.
Date: November 7, 2025
| HARVARD APPARATUS REGENERATIVE TECHNOLOGY, INC. | |
| By: | /s/ Junli He |
| Name: | Junli He |
| Title: | Chief Executive Officer, Director, and Chairman (principal executive officer) |
| By: | /s/ Joseph L.Damasio Jr. |
| Name: | Joseph L. Damasio Jr. |
| Title: | Chief Financial Officer (principal financial and accounting officer) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.